These final results, along with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the idea of concentrating on ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-associated disorders. Disclaimer: The above is https://wardp368rnh7.dreamyblogs.com/profile